Ponoi II Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $17M | Hold |
1,298,908
| – | – | 44.41% | 1 |
|
|
2022
Q2 | $16.7M | Hold |
1,298,908
| – | – | 45.25% | 1 |
|
|
2022
Q1 | $19.8M | Hold |
1,298,908
| – | – | 43.96% | 1 |
|
|
2021
Q4 | $23M | Hold |
1,298,908
| – | – | 41.78% | 1 |
|
|
2021
Q3 | $27.3M | Hold |
1,298,908
| – | – | 40.46% | 1 |
|
|
2021
Q2 | $25.6M | Hold |
1,298,908
| – | – | 20.76% | 2 |
|
|
2021
Q1 | $37.8M | Hold |
1,298,908
| – | – | 28.92% | 1 |
|
|
2020
Q4 | $39.4M | Buy |
+1,298,908
| New | +$39.4M | 28.68% | 2 |
|